{"meta":{"query_hash":"9a43560aa3fc","filters":{"venue":"Pharmaceutical Medicine"},"cohort_total":26,"direct_labels_cover":0,"predictions_cover":26,"exported":26,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9a43560aa3fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceutical+Medicine"},"results":[{"id":"W103748181","doi":"10.1007/bf03256813","title":"The Changing Face of Direct-to-Consumer Print Advertising","year":2010,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Georgia","keywords":"Advertising; Order (exchange); Quarter (Canadian coin); Business; Balance (ability); Over-the-counter; Content analysis; Medical prescription; Medicine","score_opus":0.3249485468030795,"score_gpt":0.5636868487637329,"score_spread":0.23873830196065338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W103748181","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056543767,0.015235541,0.0034867078,0.54992294,0.0062120873,0.00003459562,0.00036434183,0.00027182675,0.36792827],"genre_scores_gemma":[0.7551663,0.014567777,0.0031651326,0.124309905,0.023916798,0.00004993862,0.00019495959,0.0004666528,0.078162536],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.993693,0.0014603448,0.0002194468,0.00094371237,0.0030548915,0.00062860124],"domain_scores_gemma":[0.97030807,0.017338205,0.0022193217,0.0012974555,0.0054181474,0.0034187604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069341743,0.00043926996,0.00057145266,0.0021678342,0.0043476485,0.021002911,0.0017880125,0.011006375,0.050406467],"category_scores_gemma":[0.025731167,0.00047641274,0.0004925933,0.0017327127,0.008100485,0.019574668,0.0031146235,0.008998822,0.0071233776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003239117,0.00026486957,0.009936946,0.0004808697,0.000037682337,0.0017503087,0.0110240495,0.0005603699,0.0028002977,0.43519118,0.27722046,0.26040912],"study_design_scores_gemma":[0.00003700665,0.00009603135,0.015546141,0.00046483715,0.000022013754,0.0020622856,0.013917474,0.0010136061,0.0008145129,0.09006475,0.8758327,0.00012855243],"about_ca_topic_score_codex":0.005921605,"about_ca_topic_score_gemma":0.010579335,"teacher_disagreement_score":0.050406467,"about_ca_system_score_codex":0.005220765,"about_ca_system_score_gemma":0.0023446053,"threshold_uncertainty_score":0.16862643},"labels":[],"label_agreement":null},{"id":"W1883456152","doi":"10.1007/s40290-015-0106-6","title":"Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration; Hamilton Health Sciences Foundation","keywords":"Pharmacovigilance; Outreach; Adverse effect; Medicine; Event (particle physics); Adverse drug event; Medical emergency; Medical physics; Internal medicine","score_opus":0.4049343292784165,"score_gpt":0.5660667458406965,"score_spread":0.16113241656228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1883456152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975842,0.00021155966,0.0002841221,0.0004678504,0.0000054841435,0.00016311466,0.0004155425,0.000012644525,0.000855569],"genre_scores_gemma":[0.99760324,0.00032727432,0.0005976494,0.00036141727,0.000013662241,0.000226897,0.00048529654,0.00001623555,0.00036840257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99091774,0.00450872,0.0010356418,0.00060033874,0.0018949057,0.0010427813],"domain_scores_gemma":[0.9727471,0.012054022,0.00879157,0.00106915,0.0030862151,0.0022519834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075654355,0.0003425159,0.00041427586,0.002893447,0.0011533771,0.0017552385,0.00083549944,0.0008664758,0.002219715],"category_scores_gemma":[0.034783084,0.0003750848,0.0011951204,0.0034125228,0.0007454473,0.0022327057,0.0031692204,0.0014620424,0.00032784362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005302458,0.0007478419,0.9534995,0.00019550789,0.00017856131,0.00020665824,0.010617959,0.00013480059,0.00022357958,0.00019446136,0.0012474944,0.03222333],"study_design_scores_gemma":[0.000031709227,0.00054138893,0.9860875,0.00013331216,0.0000741938,0.0001828522,0.0103790155,0.0009465549,0.00012636905,0.000089574474,0.0013838279,0.00002363641],"about_ca_topic_score_codex":0.019388318,"about_ca_topic_score_gemma":0.022965336,"teacher_disagreement_score":0.019388318,"about_ca_system_score_codex":0.0016749008,"about_ca_system_score_gemma":0.0038558086,"threshold_uncertainty_score":0.040010333},"labels":[],"label_agreement":null},{"id":"W1980001858","doi":"10.1007/bf03256800","title":"Pharmaceutical Medicine in Switzerland","year":2010,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Specialty; Pharmaceutical industry; Medical education; Alternative medicine; Medicine; Pharmacy; Work (physics); Family medicine; Pharmacology; Engineering","score_opus":0.11966046848125413,"score_gpt":0.47484569267012305,"score_spread":0.35518522418886894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980001858","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11808117,0.08374888,0.00120247,0.07139847,0.0038252615,0.00008094434,0.0017799638,0.0006124552,0.71927035],"genre_scores_gemma":[0.720084,0.017546203,0.0011193533,0.0031915975,0.0016731462,0.000069265705,0.0007138559,0.0000836518,0.25551894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999025,0.00028772227,0.0000636967,0.00013260386,0.00022491053,0.00026597656],"domain_scores_gemma":[0.9988589,0.0002833836,0.0001808808,0.00007657493,0.00019550085,0.00040472805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008346531,0.00042130615,0.00021875623,0.002354981,0.0018369158,0.0029624035,0.00018884642,0.0017072464,0.04436181],"category_scores_gemma":[0.0014591508,0.00015790352,0.00024645598,0.0016628886,0.0013372909,0.0011150164,0.0019589122,0.0011875513,0.0072741075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005168415,0.00031358787,0.036418103,0.0012064234,0.00006911372,0.0037046375,0.0037754755,0.0012804448,0.011815303,0.3442144,0.23050927,0.36617643],"study_design_scores_gemma":[0.000070243004,0.000188976,0.131974,0.0005077782,0.000019205165,0.0013156002,0.001377827,0.00051135756,0.001641265,0.0055747237,0.85678816,0.000030859283],"about_ca_topic_score_codex":0.012947149,"about_ca_topic_score_gemma":0.017285192,"teacher_disagreement_score":0.04436181,"about_ca_system_score_codex":0.002605903,"about_ca_system_score_gemma":0.004421261,"threshold_uncertainty_score":0.14840502},"labels":[],"label_agreement":null},{"id":"W1986483795","doi":"10.1007/s40290-015-0090-x","title":"Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordic Life Science Pipeline (Canada)","funders":"","keywords":"Big data; Medicine; Business; Pharmacology; Computer science; Data mining","score_opus":0.3911000808631966,"score_gpt":0.48831674186369234,"score_spread":0.09721666100049575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986483795","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00995212,0.052061424,0.20302552,0.672869,0.012015004,0.0005285871,0.0019422482,0.0019576224,0.04564833],"genre_scores_gemma":[0.20616251,0.11222983,0.5221052,0.10798321,0.023746727,0.0013905639,0.005047191,0.0016049319,0.019729825],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98030776,0.008369987,0.0012303442,0.0013994289,0.007333781,0.0013587496],"domain_scores_gemma":[0.9448499,0.02528062,0.0026866882,0.008714805,0.010831439,0.007636594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05427015,0.0018328574,0.0021449989,0.0062283543,0.0034026415,0.022309955,0.006219173,0.009735925,0.008487879],"category_scores_gemma":[0.057499353,0.0014844567,0.002011797,0.009135667,0.008012653,0.042857233,0.021317545,0.011895289,0.007033562],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033232465,0.00034708637,0.00410364,0.0019514451,0.000324186,0.00050937035,0.0009494842,0.0089134155,0.0025549603,0.48413107,0.20603617,0.28984678],"study_design_scores_gemma":[0.00009442326,0.00009811407,0.00081574573,0.0012160356,0.000058123456,0.00013642643,0.0009911325,0.01095689,0.0016637918,0.61525893,0.3686148,0.00009556672],"about_ca_topic_score_codex":0.002437179,"about_ca_topic_score_gemma":0.0024032737,"teacher_disagreement_score":0.05427015,"about_ca_system_score_codex":0.0038499248,"about_ca_system_score_gemma":0.017017856,"threshold_uncertainty_score":0.28701138},"labels":[],"label_agreement":null},{"id":"W2287309625","doi":"10.1007/s40290-015-0124-4","title":"The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore","year":2015,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Excellence; Transparency (behavior); Certification; Agency (philosophy); Business; Health care; Timeline; Medicine; Product (mathematics); Public relations; Political science; Sociology","score_opus":0.3241643169139876,"score_gpt":0.49964211922415575,"score_spread":0.17547780231016813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287309625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97284657,0.005681028,0.00056605233,0.0047796667,0.00008667697,0.0008967932,0.0004391717,0.00008404202,0.0146200545],"genre_scores_gemma":[0.9924706,0.0023179082,0.0016007964,0.0008290001,0.00002216726,0.00012687476,0.00024333979,0.000022811562,0.0023664997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94672585,0.020314485,0.0051613855,0.0016809335,0.023632303,0.0024850098],"domain_scores_gemma":[0.8005478,0.047161482,0.039004724,0.0046506473,0.091538765,0.01709664],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05999889,0.00028980308,0.0003789638,0.0055919266,0.0038817304,0.005646359,0.0013694788,0.0010779168,0.0024437448],"category_scores_gemma":[0.075863734,0.00044285276,0.0005587017,0.0049886163,0.002729187,0.0018687343,0.0032032186,0.0007975891,0.00037002712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022315194,0.0006685221,0.67181593,0.0025448382,0.00026766895,0.0011496483,0.062096175,0.00068069407,0.0033737833,0.0036217007,0.008292195,0.24325734],"study_design_scores_gemma":[0.00016927598,0.0014125038,0.88352334,0.0009021416,0.00015920245,0.00080244604,0.051208798,0.001249016,0.0018900272,0.00014536858,0.05836747,0.00017029185],"about_ca_topic_score_codex":0.40741983,"about_ca_topic_score_gemma":0.44353375,"teacher_disagreement_score":0.94000113,"about_ca_system_score_codex":0.031068683,"about_ca_system_score_gemma":0.07886623,"threshold_uncertainty_score":0.81009674},"labels":[],"label_agreement":null},{"id":"W2342279036","doi":"10.1007/s40290-016-0142-x","title":"Content Related to Older Adults in Canadian Innovator–Drug Product Monographs: An Exploratory Analysis","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Innovator; Geriatrics; Notice; Product (mathematics); Population; Gerontology; Family medicine; Computer science; Environmental health; Psychiatry","score_opus":0.1531829746538198,"score_gpt":0.42332776015447854,"score_spread":0.27014478550065874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342279036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920787,0.00070882536,0.00007264261,0.00026848164,0.000009987154,0.000208672,0.00410428,0.00000791066,0.0025405567],"genre_scores_gemma":[0.9931693,0.000835938,0.0005544378,0.00040850425,0.00003415497,0.00022836364,0.0033953039,0.000014888482,0.0013590602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657923,0.00041956303,0.0004276864,0.00025344535,0.0016294762,0.0006906081],"domain_scores_gemma":[0.961535,0.01333556,0.010544997,0.0004897527,0.010269471,0.0038253304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037145761,0.0003057142,0.0005449872,0.009879291,0.002381069,0.0025276416,0.0010470324,0.0008647265,0.0032359418],"category_scores_gemma":[0.028678719,0.00022285216,0.0007866361,0.011351703,0.0009999969,0.0010683383,0.0022562344,0.0010806503,0.00024146291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032288735,0.00020342237,0.9641085,0.0003697289,0.00010910234,0.00014662267,0.01939849,0.000042563268,0.0003009305,0.00017577813,0.0017583004,0.013063651],"study_design_scores_gemma":[0.000008105984,0.000045244935,0.98612404,0.00011104569,0.00006357592,0.000040566658,0.011551992,0.00007002855,0.00006664593,0.000021369258,0.0018867103,0.0000105721365],"about_ca_topic_score_codex":0.81020176,"about_ca_topic_score_gemma":0.8716773,"teacher_disagreement_score":0.18979824,"about_ca_system_score_codex":0.022452572,"about_ca_system_score_gemma":0.03134236,"threshold_uncertainty_score":0.38183194},"labels":[],"label_agreement":null},{"id":"W2567239969","doi":"10.1007/s40290-016-0172-4","title":"The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore","year":2016,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Timeline; Food and drug administration; Regulatory affairs; Agency (philosophy); Medicine; Certificate; Business; Medical education; Political science; Public administration; Environmental health; Computer science; Sociology","score_opus":0.15703231075620758,"score_gpt":0.4712236755776073,"score_spread":0.31419136482139975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567239969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.671095,0.02629941,0.003296691,0.034249756,0.0006024882,0.0028091737,0.003907763,0.0005979202,0.2571417],"genre_scores_gemma":[0.93975335,0.010439916,0.0056438907,0.006710508,0.00013753813,0.00040487666,0.0025060168,0.00016272342,0.034241185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9712742,0.0069667934,0.0020074288,0.0013310382,0.01629326,0.0021272488],"domain_scores_gemma":[0.9298582,0.009508683,0.0088574225,0.0017546271,0.0427507,0.0072704772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027431706,0.00029658672,0.00027990554,0.0034145068,0.002445966,0.0051490283,0.0012818128,0.00088858267,0.005542532],"category_scores_gemma":[0.04180086,0.0003203108,0.00050118385,0.005893929,0.0014508242,0.001588114,0.0018540485,0.0009029429,0.0013643367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016077613,0.00047115755,0.4263487,0.0017727041,0.0001909232,0.0013567725,0.015698783,0.0010017602,0.002666732,0.016257325,0.06590999,0.46671748],"study_design_scores_gemma":[0.00017116462,0.0007615577,0.69337124,0.00075931713,0.00009586459,0.0011202241,0.011679662,0.0016510942,0.0023667212,0.00041104842,0.28748277,0.00012932351],"about_ca_topic_score_codex":0.6437771,"about_ca_topic_score_gemma":0.6721751,"teacher_disagreement_score":0.35622293,"about_ca_system_score_codex":0.026837774,"about_ca_system_score_gemma":0.09718445,"threshold_uncertainty_score":0.71664155},"labels":[],"label_agreement":null},{"id":"W2615558757","doi":"10.1007/s40290-017-0191-9","title":"Myths and Realities About Why Prescription Drug Prices in the United States Are So High","year":2017,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Medical prescription; Drug; Medicine; Pharmacotherapy; Mythology; Drug prices; Environmental health; Political science; Family medicine; Traditional medicine; Pharmacology; Psychiatry; Public economics; Economics; History","score_opus":0.11022600024979189,"score_gpt":0.3562483066323625,"score_spread":0.2460223063825706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615558757","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06899132,0.008958888,0.0012695576,0.9042188,0.0012539397,0.0000075292182,0.0004162306,0.000026746142,0.014856951],"genre_scores_gemma":[0.91372406,0.006913597,0.00053868233,0.07516855,0.0025254278,0.0000159544,0.00012238175,0.000028457203,0.00096289994],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9962484,0.00135103,0.00021619508,0.00070683396,0.0009385329,0.0005389438],"domain_scores_gemma":[0.9555387,0.027082475,0.010175871,0.0011460903,0.0038208184,0.002236068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076161595,0.0002255376,0.00035393442,0.0012943372,0.0012801376,0.005231169,0.0009034011,0.005110666,0.0038453704],"category_scores_gemma":[0.054177303,0.0003715949,0.00039910464,0.001852563,0.010037067,0.0059610237,0.0013005468,0.0075190878,0.00042850716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061769906,0.00030809158,0.16795446,0.00084193866,0.0006881356,0.00082384347,0.010726147,0.0043309852,0.0006417256,0.45382497,0.27009797,0.08914399],"study_design_scores_gemma":[0.00018099461,0.00007666461,0.14884315,0.0014342924,0.00017993788,0.0005746735,0.024542471,0.004852338,0.0014527445,0.6838256,0.13381958,0.00021754531],"about_ca_topic_score_codex":0.010175117,"about_ca_topic_score_gemma":0.0092181545,"teacher_disagreement_score":0.010175117,"about_ca_system_score_codex":0.0033485466,"about_ca_system_score_gemma":0.0032329732,"threshold_uncertainty_score":0.040278614},"labels":[],"label_agreement":null},{"id":"W2941706251","doi":"10.1007/s40290-019-00278-z","title":"Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada)","funders":"Bayer","keywords":"Aflibercept; Medicine; Key (lock); Risk analysis (engineering); Intensive care medicine; Risk assessment; Surgery; Computer science; Chemotherapy","score_opus":0.08479523333586769,"score_gpt":0.39559780974420333,"score_spread":0.31080257640833564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941706251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852822,0.0010934582,0.00041161737,0.0013367382,0.000025857407,0.00097168284,0.0014707837,0.000051128238,0.00935639],"genre_scores_gemma":[0.99658006,0.0005005241,0.0011501624,0.00021714495,0.0000104788905,0.00016088363,0.0005146381,0.0000045232123,0.0008616261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933014,0.0012053325,0.0006526954,0.00036540584,0.003853962,0.00062122435],"domain_scores_gemma":[0.9620465,0.007469537,0.0077246474,0.00050917466,0.017666766,0.00458337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00595187,0.0003255522,0.00047805297,0.0015550472,0.0017137333,0.0008491393,0.0011691271,0.00062815566,0.003683115],"category_scores_gemma":[0.03212691,0.00033441087,0.0006524881,0.0021014612,0.00086668716,0.00068454735,0.000866111,0.0006896037,0.0002849808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011155782,0.00097490044,0.945956,0.0005623379,0.00013828953,0.00010145934,0.0024208478,0.000509189,0.00035157133,0.000113829185,0.0027720556,0.044983964],"study_design_scores_gemma":[0.00012450643,0.0007858763,0.99451494,0.00011275391,0.00007250638,0.000052818836,0.0011592843,0.0011570686,0.00024931712,0.000024012395,0.0017232546,0.00002381233],"about_ca_topic_score_codex":0.89150333,"about_ca_topic_score_gemma":0.9015791,"teacher_disagreement_score":0.97385514,"about_ca_system_score_codex":0.026144836,"about_ca_system_score_gemma":0.04563308,"threshold_uncertainty_score":0.2182712},"labels":[],"label_agreement":null},{"id":"W2987745860","doi":"10.1007/s40290-019-00306-y","title":"Current Landscape of Late-Phase Clinical Trials for Alzheimer’s Disease: Comparing Regional Variation Between Subjects in Japan and North America","year":2019,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"Clinical trial; Medicine; Clinical endpoint; Population; Observational study; Clinical Dementia Rating; Disease; Dementia; Internal medicine; Environmental health","score_opus":0.41007262536455885,"score_gpt":0.5541037621333915,"score_spread":0.14403113676883267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987745860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64148486,0.27656648,0.008179152,0.053372197,0.0010154333,0.0006060989,0.003790545,0.00014102877,0.0148442015],"genre_scores_gemma":[0.9675502,0.015668767,0.00498135,0.008524361,0.00083205476,0.00036322922,0.0016221466,0.000069534144,0.00038832027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9290491,0.04928214,0.010398669,0.005230016,0.004285021,0.0017551094],"domain_scores_gemma":[0.7951075,0.10307157,0.048086993,0.008290778,0.036058087,0.00938509],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.099826336,0.00043930302,0.0024851947,0.0031102793,0.0011903214,0.004344805,0.0017914318,0.0010470898,0.001742209],"category_scores_gemma":[0.11706155,0.000556285,0.0014314634,0.0055782823,0.002553905,0.0027038713,0.0016723019,0.0012608021,0.00027273074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071587623,0.00050480734,0.76014835,0.0035670828,0.004125807,0.00016193344,0.0020132742,0.0009990003,0.0017851931,0.0040637855,0.010127426,0.20534468],"study_design_scores_gemma":[0.00085805455,0.0015482986,0.9705372,0.0016338064,0.0022104261,0.00030017976,0.002214591,0.0009558734,0.00035869348,0.0027316485,0.016579926,0.00007129125],"about_ca_topic_score_codex":0.019634377,"about_ca_topic_score_gemma":0.040314797,"teacher_disagreement_score":0.90017366,"about_ca_system_score_codex":0.0038228855,"about_ca_system_score_gemma":0.0091410475,"threshold_uncertainty_score":0.5279384},"labels":[],"label_agreement":null},{"id":"W3010852553","doi":"10.1007/s40290-020-00329-w","title":"US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Adverse Event Reporting System; Food and drug administration; Adverse effect; Medicine; Drug; Food safety; Environmental health; Emergency medicine; Pharmacology","score_opus":0.20345642122992655,"score_gpt":0.47564872300221445,"score_spread":0.2721923017722879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010852553","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03246432,0.018549984,0.10385513,0.061365325,0.00898831,0.018011283,0.32424325,0.02187622,0.4106461],"genre_scores_gemma":[0.21730511,0.027366491,0.17528042,0.07696211,0.0066626263,0.017528784,0.36713398,0.0024824021,0.10927809],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9713032,0.00961176,0.0068735476,0.0014919378,0.009710562,0.0010089331],"domain_scores_gemma":[0.80708456,0.047516145,0.04509468,0.01468462,0.08114378,0.00447627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022594623,0.001139287,0.0016632576,0.008200706,0.0012847082,0.003712856,0.0022403118,0.0038434674,0.026332978],"category_scores_gemma":[0.106616996,0.0007464368,0.0020620713,0.0072637373,0.00077947974,0.001885653,0.0014689035,0.00398992,0.012695119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089553476,0.0008544763,0.035557173,0.0020029158,0.0005180546,0.00030779943,0.00022680916,0.0014488355,0.003797287,0.009034003,0.67552733,0.26982984],"study_design_scores_gemma":[0.00080974586,0.00077962264,0.08687391,0.002185274,0.0006552602,0.0011328146,0.00021343883,0.0047933166,0.0081931595,0.0076665315,0.88648564,0.00021125095],"about_ca_topic_score_codex":0.0153945135,"about_ca_topic_score_gemma":0.008883152,"teacher_disagreement_score":0.026332978,"about_ca_system_score_codex":0.0028671683,"about_ca_system_score_gemma":0.015197874,"threshold_uncertainty_score":0.11949319},"labels":[],"label_agreement":null},{"id":"W3042380614","doi":"10.1007/s40290-020-00345-w","title":"Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study","year":2020,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Université du Québec à Trois-Rivières","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Postmarketing surveillance; Adverse drug reaction; Data quality; Pharmacoepidemiology; Descriptive statistics; Drug; Pharmacology; Database; Adverse effect; Business; Marketing; Computer science; Statistics","score_opus":0.7319876051940398,"score_gpt":0.5953530109512966,"score_spread":0.13663459424274327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042380614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9168526,0.0012441796,0.0049787927,0.0012073178,0.00008686779,0.013027144,0.050025396,0.0001595088,0.01241814],"genre_scores_gemma":[0.9441758,0.0008431147,0.016512768,0.0016320342,0.00008854985,0.0052958173,0.02905522,0.00007354173,0.0023231083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96466774,0.009344156,0.0034832084,0.0026126266,0.017273795,0.002618571],"domain_scores_gemma":[0.9030915,0.022327479,0.011249094,0.006127276,0.053827487,0.0033772523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02586521,0.0014158302,0.0013002544,0.0063462965,0.0035841968,0.00335978,0.0029479295,0.0016620243,0.0034835534],"category_scores_gemma":[0.08209559,0.0007874502,0.002200712,0.012587592,0.0013365619,0.0017639063,0.0023216764,0.001382933,0.00095208926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026261224,0.0017441646,0.95022017,0.0009279409,0.00088900316,0.00035787918,0.002278506,0.0011754404,0.0008029054,0.001014685,0.007832881,0.030130276],"study_design_scores_gemma":[0.000905734,0.0012824999,0.9796718,0.00022589669,0.0007492065,0.0002694034,0.0016010524,0.003068893,0.00075352227,0.00019330978,0.011153359,0.00012530333],"about_ca_topic_score_codex":0.94697535,"about_ca_topic_score_gemma":0.94486046,"teacher_disagreement_score":0.96566844,"about_ca_system_score_codex":0.034331568,"about_ca_system_score_gemma":0.0916106,"threshold_uncertainty_score":0.24909413},"labels":[],"label_agreement":null},{"id":"W3121676279","doi":"10.1007/s40290-020-00370-9","title":"Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019","year":2021,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Public Health Ontario; McMaster University; University of Toronto","funders":"","keywords":"Enforcement; Revenue; Promotion (chess); Advertising; Business; Medical prescription; Food and drug administration; Prescription drug; Medicine; Marketing; Accounting; Environmental health; Pharmacology; Political science; Law","score_opus":0.3513951824707327,"score_gpt":0.5601475269582138,"score_spread":0.2087523444874811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121676279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986126,0.0005046699,0.00014404271,0.0004985525,0.00002551412,0.000022614238,0.0107729,0.000025616373,0.0018802036],"genre_scores_gemma":[0.9880602,0.00030843518,0.000120681194,0.00016031846,0.000024561377,0.000029797715,0.009553568,0.000013655104,0.0017287312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976031,0.00035160023,0.00045884307,0.00047789753,0.00048738567,0.000621202],"domain_scores_gemma":[0.98388034,0.00155102,0.0106382305,0.00051157334,0.002589351,0.0008294569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018628476,0.0002701449,0.00034838513,0.0037910722,0.00066547777,0.0019564107,0.0009808157,0.0013015678,0.0038261078],"category_scores_gemma":[0.008049319,0.00044341118,0.00091299857,0.0063883844,0.0003534066,0.002022804,0.0012641395,0.0015147735,0.0014096879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013060363,0.00008115871,0.9965411,0.00001621384,0.00007441983,0.000046314424,0.00019317547,0.00006463247,0.00004015774,0.00004089491,0.0009300089,0.0018412754],"study_design_scores_gemma":[0.0000027977528,0.000055692013,0.9979361,0.000016936094,0.00002547841,0.00008162357,0.00065712474,0.0003414801,0.000035031313,0.000015614169,0.0008246854,0.000007501999],"about_ca_topic_score_codex":0.09051014,"about_ca_topic_score_gemma":0.12117208,"teacher_disagreement_score":0.09051014,"about_ca_system_score_codex":0.001649275,"about_ca_system_score_gemma":0.002018644,"threshold_uncertainty_score":0.17996663},"labels":[],"label_agreement":null},{"id":"W3193700822","doi":"10.1007/s40290-021-00397-6","title":"The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic","year":2021,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Authorization; Pandemic; Coronavirus disease 2019 (COVID-19); Medical emergency; 2019-20 coronavirus outbreak; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Business; Computer security; Virology; Infectious disease (medical specialty); Disease; Outbreak; Computer science","score_opus":0.4623289032833736,"score_gpt":0.5408226501648542,"score_spread":0.07849374688148059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193700822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005765555,0.99831676,0.000039261726,0.0006658611,0.00011892785,0.0000027848525,0.000019697014,0.0000029342684,0.00077619136],"genre_scores_gemma":[0.000824753,0.9977863,0.00010472256,0.00081534917,0.00021322124,0.000004286056,0.00002152257,0.0000016000065,0.0002283293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989145,0.00030579837,0.00015358278,0.00016027463,0.000364093,0.00010170436],"domain_scores_gemma":[0.992326,0.005391168,0.0010401831,0.00010751387,0.0008705817,0.00026467722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030918487,0.00083920994,0.0020126377,0.0032899322,0.00044812483,0.0028725718,0.0012164471,0.0032967692,0.005636695],"category_scores_gemma":[0.0068364665,0.0004710062,0.0013264044,0.0039809863,0.0014848802,0.0029473857,0.0012316627,0.004689935,0.0013275443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016490616,0.00005673106,0.00022795518,0.01857157,0.00017027378,0.00014235172,0.00009775809,0.00036607878,0.000350869,0.011258297,0.038564358,0.93002886],"study_design_scores_gemma":[0.000053353837,0.00009679992,0.0010578205,0.015603791,0.00021188079,0.00056202634,0.00008605237,0.00010630378,0.00015024857,0.002278537,0.97976583,0.00002740766],"about_ca_topic_score_codex":0.0050950907,"about_ca_topic_score_gemma":0.011553025,"teacher_disagreement_score":0.005636695,"about_ca_system_score_codex":0.0024694824,"about_ca_system_score_gemma":0.005338362,"threshold_uncertainty_score":0.018856585},"labels":[],"label_agreement":null},{"id":"W3203314040","doi":"10.1007/s40290-021-00402-y","title":"How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream","year":2021,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Pandemic; Drug development; Mainstream; Pharmacovigilance; Public health; Medicine; Coronavirus disease 2019 (COVID-19); Pharmaceutical industry; Procurement; Business; Public relations; Political science; Drug; Economic growth; Pharmacology; Disease; Infectious disease (medical specialty); Marketing","score_opus":0.24169205724386084,"score_gpt":0.4934767466812031,"score_spread":0.2517846894373423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203314040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039535542,0.99714214,0.000041129126,0.0017579868,0.0003059197,0.000002920821,0.000025324423,0.0000038082994,0.0006812643],"genre_scores_gemma":[0.0004666421,0.997577,0.00008864233,0.001268414,0.00022772998,0.000005333269,0.000024481995,0.0000012730504,0.00034042177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999373,0.00018893727,0.00007020437,0.000090632435,0.00019373753,0.00008354342],"domain_scores_gemma":[0.99792707,0.0012946089,0.00018868082,0.000033308814,0.0004343963,0.000121850884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000942,0.0008715222,0.0018891509,0.0026810674,0.00039302272,0.0025675674,0.00089572533,0.0030328066,0.0076995664],"category_scores_gemma":[0.0033666843,0.00040998525,0.0010685985,0.0030269383,0.0008077618,0.0032613643,0.0011273313,0.0043325797,0.002031509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017637285,0.000069170506,0.00013340317,0.032714747,0.00027190484,0.00012373267,0.00011630239,0.0005164967,0.0008321906,0.017512504,0.069117256,0.87841594],"study_design_scores_gemma":[0.000052244093,0.00008412401,0.00048547404,0.016562166,0.00025075156,0.00022908201,0.000107574386,0.000083364816,0.0001332584,0.004806938,0.9771828,0.000022216638],"about_ca_topic_score_codex":0.004907985,"about_ca_topic_score_gemma":0.011726124,"teacher_disagreement_score":0.0076995664,"about_ca_system_score_codex":0.002363694,"about_ca_system_score_gemma":0.005702421,"threshold_uncertainty_score":0.02575767},"labels":[],"label_agreement":null},{"id":"W4242306480","doi":"10.1093/med/9780199609147.003.0012","title":"Health Canada","year":2013,"lang":"en","type":"book-chapter","venue":"Pharmaceutical Medicine","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.17063958525648087,"score_gpt":0.5016619708817266,"score_spread":0.3310223856252457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242306480","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002588444,0.0016241451,0.00023248601,0.002985722,0.00054872147,0.000042108477,0.006074265,0.00021689288,0.9880167],"genre_scores_gemma":[0.00081848726,0.0007431003,0.00017079167,0.00071619503,0.00003219303,0.000013521155,0.0009738705,0.000066525594,0.9964653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902904,0.000052069612,0.000023034598,0.00016123346,0.000528392,0.00020622152],"domain_scores_gemma":[0.9987419,0.00012417942,0.00003253824,0.000058189347,0.0008274836,0.00021575805],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041751692,0.0010688691,0.00079217064,0.0022799487,0.0040964144,0.0043039117,0.0012937173,0.002572676,0.5015486],"category_scores_gemma":[0.0020483949,0.00060962763,0.0004590652,0.0038991745,0.0007709761,0.0013282911,0.0011002325,0.0021833812,0.24579129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001258064,0.000014341149,0.00017545115,0.000048883918,0.0000019295337,0.000039482737,0.000024339623,0.000059702383,0.000050398925,0.009069238,0.94701266,0.04349094],"study_design_scores_gemma":[0.0000067725973,0.00000294528,0.00046532156,0.000053090203,0.0000020458797,0.000021772285,0.00004266804,0.000064012136,0.00004586746,0.0009973347,0.9982936,0.0000044892727],"about_ca_topic_score_codex":0.81977606,"about_ca_topic_score_gemma":0.9237812,"teacher_disagreement_score":0.9820878,"about_ca_system_score_codex":0.017912202,"about_ca_system_score_gemma":0.03863664,"threshold_uncertainty_score":0.7109804},"labels":[],"label_agreement":null},{"id":"W4308697730","doi":"10.1007/s40290-022-00447-7","title":"The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes","year":2022,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada)","funders":"","keywords":"Clinical trial; Medicine; Cannabis; Synthetic cannabinoids; Randomized controlled trial; Drug development; Drug; Cannabinoid; Pharmacology; Psychiatry; Internal medicine","score_opus":0.6472075699016272,"score_gpt":0.6247242841693867,"score_spread":0.022483285732240454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308697730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014917017,0.99917847,0.00011251711,0.00016393782,0.00004400044,0.00004765979,0.00010346116,0.0000030418064,0.00019766718],"genre_scores_gemma":[0.0024317252,0.99599105,0.00069123803,0.00048664198,0.00007840109,0.00008398809,0.00012361615,0.0000047831863,0.000108557426],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925296,0.002076821,0.0028419173,0.00086214766,0.0015001139,0.0001893877],"domain_scores_gemma":[0.9506726,0.038540278,0.006967385,0.00048093815,0.0028471746,0.000491594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011910554,0.0014362119,0.0066686217,0.0068152673,0.00040091938,0.0034262468,0.00211242,0.0022943758,0.0048045856],"category_scores_gemma":[0.03392566,0.0008489839,0.004340117,0.008671049,0.0011965699,0.0027261686,0.0012413947,0.0020854303,0.00067390496],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014147083,0.00008030288,0.0009130568,0.50653505,0.004748704,0.00017303492,0.00014879544,0.00040686034,0.0014045606,0.0016405592,0.005970837,0.4765636],"study_design_scores_gemma":[0.0013392082,0.001589553,0.010744977,0.51238644,0.047555957,0.00260782,0.00043704623,0.0003957663,0.0015255997,0.0035809192,0.4176713,0.00016550969],"about_ca_topic_score_codex":0.0018950268,"about_ca_topic_score_gemma":0.007111621,"teacher_disagreement_score":0.011910554,"about_ca_system_score_codex":0.0026487606,"about_ca_system_score_gemma":0.00614545,"threshold_uncertainty_score":0.06298983},"labels":[],"label_agreement":null},{"id":"W4317391044","doi":"10.1007/s40290-022-00459-3","title":"Digital Therapies (DTx) as New Tools within Physicians’ Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep Edouard Montpetit; Université de Montréal; Simon Fraser University","funders":"","keywords":"Psychological intervention; Intervention (counseling); Digital health; Engineering ethics; Medicine; Business; Risk analysis (engineering); Public relations; Political science; Health care; Engineering; Nursing","score_opus":0.23723856907933674,"score_gpt":0.458602792905748,"score_spread":0.22136422382641127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317391044","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1430597,0.1035557,0.057176687,0.20614086,0.003264828,0.00070978346,0.00030814158,0.00038932706,0.48539495],"genre_scores_gemma":[0.9112709,0.032502435,0.030961826,0.012712129,0.0012489881,0.00026648826,0.000060218797,0.00007656987,0.010900489],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9941018,0.0033737188,0.00024399465,0.00046175515,0.0013832634,0.00043534912],"domain_scores_gemma":[0.97974074,0.013807949,0.002007991,0.0013626663,0.0014565197,0.0016240625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008671271,0.00039789567,0.0003258966,0.0009882814,0.0016835268,0.007862474,0.00085416937,0.0020727431,0.0085609],"category_scores_gemma":[0.014020677,0.00020193275,0.00027929028,0.0007612798,0.008225059,0.006307663,0.0041373065,0.0036118787,0.0011782247],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022910647,0.0005553921,0.010738107,0.0019272004,0.000051073926,0.0005608866,0.01934095,0.00025838453,0.003674496,0.5500088,0.019838583,0.392817],"study_design_scores_gemma":[0.0001662806,0.0006285298,0.042407956,0.005585435,0.0001218438,0.0033799456,0.034811176,0.0013658077,0.0061619547,0.2810603,0.62421644,0.0000944392],"about_ca_topic_score_codex":0.0010051017,"about_ca_topic_score_gemma":0.0017726928,"teacher_disagreement_score":0.008671271,"about_ca_system_score_codex":0.0021921822,"about_ca_system_score_gemma":0.006931568,"threshold_uncertainty_score":0.04585862},"labels":[],"label_agreement":null},{"id":"W4372333015","doi":"10.1007/s40290-023-00474-y","title":"Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Embedding; Medicine; Disease; Ecosystem; Pharmacotherapy; Intensive care medicine; Internal medicine; Computer science; Biology; Ecology; Artificial intelligence","score_opus":0.0118236033157068,"score_gpt":0.2962372390432417,"score_spread":0.28441363572753486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372333015","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.229723,0.004124429,0.33160895,0.22984819,0.0033884074,0.0011785164,0.00026535123,0.0019302074,0.19793293],"genre_scores_gemma":[0.8788314,0.0017889865,0.09099474,0.015511213,0.00043777426,0.0006836917,0.00016688868,0.0004093588,0.011175931],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.95691735,0.03717261,0.00057375093,0.0013873412,0.0019142488,0.0020346332],"domain_scores_gemma":[0.9789508,0.010570913,0.0012922807,0.0021488396,0.0011898164,0.005847226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022081213,0.0010689521,0.0004188278,0.0010669428,0.006198915,0.013914464,0.0024621966,0.0040169326,0.00984029],"category_scores_gemma":[0.021760263,0.0005838884,0.00137408,0.00046918623,0.0141762905,0.012001575,0.028451907,0.008209002,0.0025000398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030857255,0.0012720512,0.01732334,0.0014681524,0.00023028512,0.003943695,0.4270319,0.0073372377,0.009004645,0.284337,0.050594397,0.1971487],"study_design_scores_gemma":[0.00017082598,0.00092074374,0.002172027,0.0016023949,0.00012012759,0.0033995165,0.16179022,0.006459641,0.0043141018,0.18622935,0.632605,0.00021609031],"about_ca_topic_score_codex":0.0009433846,"about_ca_topic_score_gemma":0.0018433278,"teacher_disagreement_score":0.022081213,"about_ca_system_score_codex":0.0035167115,"about_ca_system_score_gemma":0.010113399,"threshold_uncertainty_score":0.116778016},"labels":[],"label_agreement":null},{"id":"W4377221230","doi":"10.1007/s40290-023-00478-8","title":"Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries","year":2023,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fondation Pierre Fabre","keywords":"Pharmacovigilance; Medicine; Pharmacotherapy; Traditional medicine; Pharmacology; Drug; Psychiatry","score_opus":0.2678028493135785,"score_gpt":0.44213186868439086,"score_spread":0.17432901937081235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377221230","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2225944,0.55405456,0.00388339,0.19856408,0.000793344,0.000080419704,0.0026957765,0.00033548535,0.016998442],"genre_scores_gemma":[0.8610009,0.10956058,0.0070477873,0.019095957,0.0011617814,0.000056842284,0.0013224832,0.000042057454,0.00071154744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920372,0.0030450476,0.0014635973,0.0008142755,0.0018005086,0.0008393878],"domain_scores_gemma":[0.95869654,0.0185553,0.01013967,0.00072155637,0.009626647,0.0022603322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021041181,0.00036530747,0.0010372096,0.003677983,0.00074328657,0.0052629365,0.0020036804,0.0015136739,0.0027143245],"category_scores_gemma":[0.02635928,0.00021282605,0.00074769405,0.004379997,0.0013008441,0.0021213586,0.0014592988,0.0010863981,0.00024354264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006312486,0.00024074037,0.3539158,0.008705881,0.0006952723,0.0015086827,0.0049276194,0.0010363247,0.0016996268,0.015252408,0.022660857,0.5887255],"study_design_scores_gemma":[0.00017986451,0.0009087116,0.60247993,0.019081298,0.0017085097,0.0059367884,0.0238265,0.0048150863,0.0024185511,0.009311237,0.3290873,0.00024634504],"about_ca_topic_score_codex":0.04826011,"about_ca_topic_score_gemma":0.03465642,"teacher_disagreement_score":0.04826011,"about_ca_system_score_codex":0.0051215,"about_ca_system_score_gemma":0.012730154,"threshold_uncertainty_score":0.11127776},"labels":[],"label_agreement":null},{"id":"W4400475270","doi":"10.1007/s40290-024-00529-8","title":"Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials","year":2024,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Generalizability theory; Inclusion (mineral); Clinical trial; Diversity (politics); Equity (law); Medicine; Disease; Relevance (law); Management science; Psychology; Pathology; Political science","score_opus":0.4169885344615545,"score_gpt":0.6002199609442508,"score_spread":0.1832314264826963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400475270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047733727,0.99799806,0.0001447477,0.0011891839,0.00012328308,0.000006315251,0.00001106249,0.000004162852,0.00047544818],"genre_scores_gemma":[0.0013513828,0.9965848,0.0003431503,0.0011239159,0.00037992658,0.00001831199,0.0000169476,0.00000187819,0.00017970936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713045,0.001382884,0.00034443015,0.0002604187,0.0007310353,0.0001507442],"domain_scores_gemma":[0.98689204,0.011082704,0.0009340582,0.0001332635,0.0006869873,0.0002709643],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00930022,0.00063410035,0.0026410827,0.0024526417,0.0003025794,0.0025886735,0.0013955096,0.0024561803,0.0054153944],"category_scores_gemma":[0.01352889,0.0003284806,0.0010003152,0.0025811656,0.001226118,0.002249727,0.0018634133,0.0030190742,0.00078546983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010844606,0.00003807915,0.00018909179,0.025448924,0.00028401802,0.00008593004,0.00007175609,0.00027573976,0.00019191502,0.012611737,0.01826396,0.94243044],"study_design_scores_gemma":[0.00031743053,0.00018129732,0.0023484128,0.051255077,0.0010182862,0.0010011382,0.00017522473,0.0003098839,0.00025765455,0.02420286,0.91887987,0.00005279123],"about_ca_topic_score_codex":0.0013394476,"about_ca_topic_score_gemma":0.004193716,"teacher_disagreement_score":0.99069977,"about_ca_system_score_codex":0.0019129999,"about_ca_system_score_gemma":0.00329369,"threshold_uncertainty_score":0.04918486},"labels":[],"label_agreement":null},{"id":"W4411639738","doi":"10.1007/s40290-025-00573-y","title":"Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators","year":2025,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; University of Sydney","keywords":"Pharmacology; Medicine; Environmental health; Business","score_opus":0.1384110428210106,"score_gpt":0.4996191888193955,"score_spread":0.3612081459983849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411639738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867214,0.0038377352,0.0010198962,0.0006145209,0.000071595765,0.0009972557,0.0010124082,0.000030833773,0.0056942864],"genre_scores_gemma":[0.994655,0.0014689955,0.0014116775,0.00055790186,0.000041534222,0.0007482612,0.0006713302,0.000037782193,0.0004077089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.91184556,0.04471876,0.019986307,0.00426923,0.01681929,0.0023608373],"domain_scores_gemma":[0.734529,0.15769704,0.06712006,0.007844892,0.02838027,0.004428731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055501137,0.00039491695,0.0013511485,0.0069365883,0.0015848201,0.0043159933,0.0013805999,0.001775843,0.0037146609],"category_scores_gemma":[0.23450053,0.0007908059,0.0026763272,0.0060713356,0.0031971615,0.005766638,0.005873007,0.0018685804,0.00050987845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012969339,0.0013072267,0.8318918,0.0068234922,0.0039616674,0.0003988176,0.050692983,0.0007347676,0.0017647352,0.0020372602,0.0020754177,0.08534239],"study_design_scores_gemma":[0.00090508896,0.0048423377,0.9193374,0.0033590568,0.0027558885,0.0006606684,0.048894074,0.001173956,0.0018157688,0.0011170998,0.01489215,0.0002466349],"about_ca_topic_score_codex":0.009693021,"about_ca_topic_score_gemma":0.008660468,"teacher_disagreement_score":0.055501137,"about_ca_system_score_codex":0.005671376,"about_ca_system_score_gemma":0.005402573,"threshold_uncertainty_score":0.29352158},"labels":[],"label_agreement":null},{"id":"W4416741600","doi":"10.1093/med/9780198842255.003.0015","title":"Health Canada","year":2025,"lang":"en","type":"book-chapter","venue":"Pharmaceutical Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Clinical trial; Drug; Pharmacotherapy; MEDLINE; Public health; Drug trial","score_opus":0.5064515909366728,"score_gpt":0.5088575807551402,"score_spread":0.0024059898184674022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416741600","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003592511,0.0018702059,0.00021813177,0.007578113,0.0005572086,0.000064424115,0.018676085,0.0003269263,0.97034967],"genre_scores_gemma":[0.0024316132,0.0010437927,0.0003896782,0.0026681582,0.000063028005,0.000025976673,0.004749813,0.00010375757,0.988524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981433,0.00007834649,0.000043754524,0.00020204583,0.0011847124,0.00034769013],"domain_scores_gemma":[0.99689555,0.00015742917,0.000055537676,0.00009554446,0.0023729815,0.00042300206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006851723,0.00071590074,0.00052392797,0.0018726677,0.0042092553,0.004944681,0.0013612158,0.0026262277,0.4078565],"category_scores_gemma":[0.0029353872,0.00050081994,0.0004923482,0.0029555203,0.00070639915,0.0009118918,0.00096264126,0.002069877,0.13862248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007122697,0.0000068079225,0.00016413463,0.00005218678,0.000001638828,0.000039666982,0.00003187903,0.00003834772,0.000045311568,0.01049012,0.96516854,0.023954201],"study_design_scores_gemma":[0.000004413381,0.0000024198118,0.0005035795,0.00005520834,0.0000013149452,0.000026573305,0.00003139742,0.000034384277,0.000036054007,0.00048312635,0.9988174,0.000004130387],"about_ca_topic_score_codex":0.9077642,"about_ca_topic_score_gemma":0.95479244,"teacher_disagreement_score":0.9620857,"about_ca_system_score_codex":0.037914246,"about_ca_system_score_gemma":0.074434794,"threshold_uncertainty_score":0.8446208},"labels":[],"label_agreement":null},{"id":"W4416837248","doi":"10.1007/s40290-025-00593-8","title":"Considerations for Biosimilar Adoption in Pediatrics: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Pharmaceutical Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biosimilar; Pharmacovigilance; New product development; Product (mathematics); Key (lock); MEDLINE; Drug development","score_opus":0.23519607778497048,"score_gpt":0.5185248198969498,"score_spread":0.2833287421119793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416837248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006867611,0.9990145,0.00005465946,0.00050098397,0.00011003629,0.000009200046,0.000020596153,0.0000023143332,0.00021902182],"genre_scores_gemma":[0.00074986287,0.998211,0.00025973006,0.00058968604,0.00007657527,0.000017314604,0.000024652161,0.0000015337013,0.00006959416],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965706,0.00084224035,0.0011850111,0.0003834522,0.00085763744,0.00016103883],"domain_scores_gemma":[0.9812036,0.013645676,0.0027777096,0.00019054803,0.0018375602,0.00034491916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009423128,0.0009749352,0.0034008955,0.0052685435,0.0005805456,0.0043735034,0.0016845553,0.003749408,0.0043666987],"category_scores_gemma":[0.019924598,0.00069727877,0.0028156464,0.0052869185,0.0011363892,0.0038196289,0.0018920143,0.003022669,0.00068253145],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021620709,0.000070025744,0.0007448666,0.23718666,0.0009147772,0.00029264396,0.0002802958,0.0004017158,0.0005194513,0.0040963115,0.019487577,0.7357894],"study_design_scores_gemma":[0.000100363664,0.00012328857,0.0015828235,0.6202297,0.003859259,0.000855094,0.000416176,0.0001745253,0.0003515372,0.0022197554,0.37004185,0.00004569424],"about_ca_topic_score_codex":0.004335284,"about_ca_topic_score_gemma":0.011125574,"teacher_disagreement_score":0.009423128,"about_ca_system_score_codex":0.0027303162,"about_ca_system_score_gemma":0.010519234,"threshold_uncertainty_score":0.049834847},"labels":[],"label_agreement":null},{"id":"W48989372","doi":"10.1007/bf03256677","title":"Drug Approval Times and User Fees","year":2008,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; University Health Network","funders":"","keywords":"Government (linguistics); Business; Agency (philosophy); Approved drug; Drug; Payment; User fee; Finance; Drug approval; Resource (disambiguation); Orphan drug; Public economics; Medicine; Pharmacology; Economics","score_opus":0.10931244738849398,"score_gpt":0.3302034876115756,"score_spread":0.2208910402230816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48989372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6781485,0.021852056,0.02177855,0.022189032,0.0006435857,0.00012163106,0.0076078856,0.00071647676,0.24694236],"genre_scores_gemma":[0.9751414,0.0015023096,0.0006193426,0.0004138546,0.00030046346,0.000018383691,0.0006914424,0.00008734085,0.021225473],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9956949,0.0015373757,0.00041737646,0.00034957688,0.0010364478,0.00096432393],"domain_scores_gemma":[0.88327456,0.08329359,0.01800349,0.003635758,0.0068129324,0.0049795946],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0038475792,0.00048282466,0.0009231283,0.0031950835,0.0010048121,0.0060810745,0.00080000353,0.0029821512,0.038272947],"category_scores_gemma":[0.08799577,0.00059802434,0.0012037262,0.0033922829,0.0011552101,0.005577478,0.001001388,0.0040883725,0.0031436516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060344273,0.00073930726,0.18754798,0.0007243319,0.00064847746,0.0019825744,0.0014342996,0.04054593,0.0022046007,0.51452893,0.053499743,0.19010939],"study_design_scores_gemma":[0.00066756207,0.0010836041,0.33639854,0.0005071425,0.0012662136,0.010871291,0.002501895,0.11054965,0.004361244,0.424262,0.10714834,0.00038256796],"about_ca_topic_score_codex":0.005491485,"about_ca_topic_score_gemma":0.0049993163,"teacher_disagreement_score":0.9961524,"about_ca_system_score_codex":0.0028675867,"about_ca_system_score_gemma":0.0014791947,"threshold_uncertainty_score":0.12803578},"labels":[],"label_agreement":null},{"id":"W53859789","doi":"10.1007/bf03256848","title":"A Proposed Framework for Formulary Listing in Low-Income Countries","year":2011,"lang":"en","type":"article","venue":"Pharmaceutical Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Formulary; Listing (finance); Psychological intervention; High income countries; Actuarial science; Medicine; Health care; Developing country; Business; Public economics; Family medicine; Economic growth; Economics; Finance; Nursing","score_opus":0.5612886048884482,"score_gpt":0.5196973706371593,"score_spread":0.04159123425128897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W53859789","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041998833,0.0016367696,0.7304707,0.0396466,0.00044901794,0.0007728308,0.0027044585,0.0006668085,0.18165395],"genre_scores_gemma":[0.69111514,0.0011026107,0.27615097,0.0022741572,0.00056338107,0.0007939577,0.0011422407,0.00009536358,0.026762139],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99455076,0.0027548308,0.0003440372,0.0009256092,0.000655733,0.0007689401],"domain_scores_gemma":[0.9905014,0.004731243,0.0010995389,0.000724444,0.0023338555,0.0006094063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006943776,0.0008000595,0.0013445005,0.002967938,0.0031168703,0.011567446,0.003111399,0.005470992,0.023161804],"category_scores_gemma":[0.01464516,0.00077542017,0.0014498092,0.0043934835,0.0034841045,0.0076734126,0.00307145,0.0029455938,0.0017171623],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010403731,0.000028514287,0.00073758455,0.000032238127,0.000013907359,0.00013160903,0.00012909266,0.007126411,0.000044540917,0.9815123,0.0042278976,0.006005439],"study_design_scores_gemma":[0.00008583683,0.000050516337,0.0014012338,0.000155567,0.000044767417,0.0002280269,0.0005892203,0.062421445,0.00019304817,0.91091996,0.023846,0.00006438011],"about_ca_topic_score_codex":0.021706363,"about_ca_topic_score_gemma":0.0227262,"teacher_disagreement_score":0.023161804,"about_ca_system_score_codex":0.004763507,"about_ca_system_score_gemma":0.0059879287,"threshold_uncertainty_score":0.07748395},"labels":[],"label_agreement":null}]}